Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese import law postponed

This article was originally published in The Gray Sheet

Executive Summary

China's government indefinitely postpones implementation of regulations that U.S. manufacturers say would otherwise delay device imports into China. Decree 95, or Administrative Measures on Examination and Supervision of Imported Medical Devices, was originally scheduled to take effect Dec. 1 (1"The Gray Sheet" Nov. 5, 2007, p. 3). Though China's Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) states that the implementation deadline will be "subsequently announced," an AdvaMed spokesperson says that "this type of indefinite suspension generally means Decree 95 is dead, unless AQSIQ re-initiates the rulemaking process at some future date.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025565

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel